TCMG
TSP Capital Management Group Portfolio holdings
AUM
$319M
This Quarter Return
+17.92%
1 Year Return
+24.13%
3 Year Return
+108.94%
5 Year Return
+211.66%
10 Year Return
+949.16%
AUM
$267M
AUM Growth
+$267M
(+13%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
45.79%
Holding
53
New
53
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CEMIG Preferred Shares
CIG
|
$15M |
| 2 |
Eli Lilly
LLY
|
$13.6M |
| 3 |
Corteva
CTVA
|
$13.3M |
| 4 |
Xylem
XYL
|
$12.9M |
| 5 |
Celldex Therapeutics
CLDX
|
$12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Materials | 24.76% |
| 2 | Healthcare | 14.77% |
| 3 | Utilities | 13.77% |
| 4 | Communication Services | 8.44% |
| 5 | Technology | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stratasys
SSYS
$863M
| $247K | 0.09% |
+20,800
| New | +$247K |
|
52
Novavax
NVAX
$1.2B
| $165K | 0.06% |
+16,025
| New | +$165K |
|
|
CALA
53
DELISTED
Calithera Biosciences, Inc
CALA
| $146K | 0.05% |
+44,750
| New | +$146K |
|